Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies.

Frontiers in aging neuroscience·2026
Same author

Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.

Neurology·2026
Same author

Head-to-head comparison of neurodegeneration biomarkers across two analytical platforms in Alzheimer's disease.

Aging clinical and experimental research·2026
Same author

Emerging directions in tauopathy research.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Estimation of positron emission tomography amyloid load and related biomarkers in Alzheimer's disease using evoked potential tomography EEG: development and internal validation in a cross-sectional cohort.

Alzheimer's research & therapy·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Sebastian Roemer-Cassiano1,2,3, Shaoshi Zhang4, Lisa Evangelista5

  • 1Department of Neurology, University Hospital, LMU Munich, Munich, Bavaria, Germany.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

阿尔茨海默病 (AD) 中的粉样质斑块驱动神经元过活,导致葡萄糖代谢增加和陶积累. 针对这种Aβ诱导的过度兴奋性可能为AD提供了一个新的治疗策略.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 医疗成像医学成像

背景情况:

  • 阿尔茨海默病 (AD) 中的粉样蛋白 (Aβ) 和病理之间的关系仍然不清楚,这使得针对Aβ-tau途径的治疗干预复杂化.
  • 临床前证据表明,Aβ增强神经元刺激性,而tau则根据神经活动扩散.
  • 最近的发现表明,与Aβ相关的连接性增加促进了tau的传播,但这是否反映了过度兴奋性是未知的.

研究的目的:

  • 调查Aβ积累是否导致阿尔茨海默病中神经元过活.
  • 为了确定这种Aβ诱导的过度活动是否会导致tau的积累.
  • 探索AD中Aβ-tau轴的潜在治疗点.

主要方法:

  • 利用休息状态fMRI与一种新的刺激/抑制 (E/I) 比率算法来评估AD频谱中的586个受试者的神经元活动.
  • 使用FDG-PET测量葡萄糖代谢,神经元活动的标志物,在638个AD频谱患者中,其中一个子集也接受了tau-PET.
  • 分析了阿尔茨海默病患者和对照者的死后脑组织,以检测c-Fos表达,这是死前神经元活动的标志物.

主要成果:

  • 在粉样蛋白阳性个体中发现了更高的E/I比率,表明了与Aβ相关的过度兴奋.
  • 观察到区域性粉素-PET和FDG-PET之间的正相关性,表明Aβ丰富区域的神经元活动增加.
  • 通过包括FDG-PET,证明了Aβ-PET对未来tau积累的预测得到了改善,而超能代谢则调解了Aβ对tau的影响.

结论:

  • Aβ积累诱导大脑向神经元过度兴奋性的转变.
  • 这种神经元过度活动表现为葡萄糖代谢的增加,这反过来又促进了与Aβ相关的积.
  • 在阿尔茨海默病中,Aβ诱导的神经元过度兴奋性是缓解Aβ-tau轴的潜在治疗标.